Stuart A. Montgomery, M.D.

Original Research

Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants: A Randomized, Double-Blind, Placebo-Controlled Study in Adult Patients With Major Depressive Disorder

March 23, 2016

Suresh Durgam, Willie Earley, Hua Guo, et al

Original Research

Extended Release Quetiapine Fumarate in Patients With Major Depressive Disorder: Suicidality Data From Acute and Maintenance Studies

May 15, 2014

Richard Weisler, Stuart A. Montgomery, Willie R. Earley, et al

Article

Late-Life Depression: Prevalence and Presentation, Course and Outcome

April 18, 2013

Stuart A. Montgomery

Article

Consensus Statement on Depression in the Elderly

April 18, 2013

Stuart A. Montgomery, Aartjan T. F. Beekman, Joel Sadavoy, et al

Article

Therapy Choices for Late-Life Depression

April 18, 2013

Stuart A. Montgomery

Original Research

Efficacy and Safety of Levomilnacipran Sustained Release in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study

April 15, 2013

Stuart A. Montgomery, Lucilla Mansuy, Adam Ruth, et al

Original Research

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

April 7, 2009

Andrew J. Cutler, Stuart A. Montgomery, David Feifel, et al

Original Research

Comparing the Rapidity of Response During Treatment of Major Depressive Disorder With Bupropion and the SSRIs: A Pooled Survival Analysis of 7 Double-Blind, Randomized Clinical Trials

December 14, 2007

George I. Papakostas, Stuart A. Montgomery, Michael E. Thase, et al

Original Research

Efficacy and Safety of Pregabalin in the Treatment of Generalized Anxiety Disorder: A 6-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Comparison of Pregabalin and Venlafaxine

May 15, 2006

Stuart A. Montgomery, Kathy Tobias, Gwen L. Zornberg, et al

Original Research

A 24-Week Randomized, Double-Blind, Placebo-Controlled Study of Escitalopram for the Prevention of Generalized Social Anxiety Disorder

October 14, 2005

Stuart A. Montgomery, Rico Nil, Natalie Dürr-Pal, et al

Original Research

Venlafaxine Versus Placebo in the Preventive Treatment of Recurrent Major Depression

March 1, 2004

Stuart A. Montgomery, Richard Entsuah, David Hackett, et al

Original Research

Partial Response and Nonresponse to Antidepressant Therapy: Current Approaches and Treatment Options

September 23, 2002

Robert M. A. Hirschfeld, Stuart A. Montgomery, Eugenio Aguglia, et al

Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants: A Randomized, Double-Blind, Placebo-Controlled Study in Adult Patients With Major Depressive Disorder

Extended Release Quetiapine Fumarate in Patients With Major Depressive Disorder: Suicidality Data From Acute and Maintenance Studies

Late-Life Depression: Prevalence and Presentation, Course and Outcome

Consensus Statement on Depression in the Elderly

Therapy Choices for Late-Life Depression

Efficacy and Safety of Levomilnacipran Sustained Release in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

Comparing the Rapidity of Response During Treatment of Major Depressive Disorder With Bupropion and the SSRIs: A Pooled Survival Analysis of 7 Double-Blind, Randomized Clinical Trials

Efficacy and Safety of Pregabalin in the Treatment of Generalized Anxiety Disorder: A 6-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Comparison of Pregabalin and Venlafaxine

A 24-Week Randomized, Double-Blind, Placebo-Controlled Study of Escitalopram for the Prevention of Generalized Social Anxiety Disorder

Venlafaxine Versus Placebo in the Preventive Treatment of Recurrent Major Depression

Partial Response and Nonresponse to Antidepressant Therapy: Current Approaches and Treatment Options

ELSEWHERE:

FOLLOW US:

Stuart A. Montgomery, M.D.

Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants: A Randomized, Double-Blind, Placebo-Controlled Study in Adult Patients With Major Depressive Disorder

Extended Release Quetiapine Fumarate in Patients With Major Depressive Disorder: Suicidality Data From Acute and Maintenance Studies

Late-Life Depression: Prevalence and Presentation, Course and Outcome

Consensus Statement on Depression in the Elderly

Therapy Choices for Late-Life Depression

Efficacy and Safety of Levomilnacipran Sustained Release in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

Comparing the Rapidity of Response During Treatment of Major Depressive Disorder With Bupropion and the SSRIs: A Pooled Survival Analysis of 7 Double-Blind, Randomized Clinical Trials

Efficacy and Safety of Pregabalin in the Treatment of Generalized Anxiety Disorder: A 6-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Comparison of Pregabalin and Venlafaxine

A 24-Week Randomized, Double-Blind, Placebo-Controlled Study of Escitalopram for the Prevention of Generalized Social Anxiety Disorder

Venlafaxine Versus Placebo in the Preventive Treatment of Recurrent Major Depression

Partial Response and Nonresponse to Antidepressant Therapy: Current Approaches and Treatment Options

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles